Therapeutic Asset Ratings

285 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
L-METHIONINE Brain Stem Glioma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Neoplasm	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Craniopharyngioma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Ependymoma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Ewing Sarcoma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Central Nervous System Neoplasm	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Medulloblastoma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Neuroblastoma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Osteosarcoma	St. Jude Children's Research Hospital	P2	CCC (53)
L-METHIONINE Other	St. Jude Children's Research Hospital	P2	CCC (53)
MERCAPTOPURINE ANHYDROUS T-Cell Non-Hodgkin Lymphoma	St. Jude Children's Research Hospital	P2	CCC (53)
Mesna Juvenile Myelomonocytic Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Mesna Myeloid Sarcoma	St. Jude Children's Research Hospital	P2	CCC (53)
Mesna Aggressive NK-Cell Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Rapamycin Juvenile Myelomonocytic Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Rapamycin Myeloid Sarcoma	St. Jude Children's Research Hospital	P2	CCC (53)
Solu-Cortef Myeloid Neoplasm	St. Jude Children's Research Hospital	P2	CCC (53)
TACROLIMUS Myeloid Sarcoma	St. Jude Children's Research Hospital	P2	CCC (53)
THIOGUANINE ANHYDROUS T-Cell Non-Hodgkin Lymphoma	St. Jude Children's Research Hospital	P2	CCC (53)
Thiotepa Myeloid Sarcoma	St. Jude Children's Research Hospital	P2	CCC (53)
Thiotepa Aggressive NK-Cell Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Azathioprine Sickle Cell Disease	St. Jude Children's Research Hospital	P2	CCC (52)
Nelarabine T-Cell Non-Hodgkin Lymphoma	St. Jude Children's Research Hospital	P2	CCC (52)
REGADENOSON Sickle Cell Disease	St. Jude Children's Research Hospital	P2	CCC (52)
Irinotecan Pediatric Solid Tumor	St. Jude Children's Research Hospital	P1/2	CCC (52)

Showing 126 to 150 of 285 assets

PreviousPage 6 of 12Next